Evidence map›Paper›PMID 35994463›Full record

ArticlePloS one2022

Association of TGFB1 rs1800469 and BCMO1 rs6564851 with coronary heart disease and IL1B rs16944 with all-cause mortality in men from the Northern Ireland PRIME study.

Rachel E Mooney, Gerry J Linden, Lewis Winning, Katie Linden, Frank Kee, Pascal P McKeown, Jayne V Woodside, Christopher C Patterson, Gareth J McKay

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Rachel E MooneyCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Gerry J LindenCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Lewis WinningDublin Dental University Hospital, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0002-8783-8089
Katie LindenCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Frank KeeCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Pascal P McKeownCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Jayne V WoodsideCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Christopher C PattersonCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Gareth J McKayCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.ORCID 0000-0001-8197-6280
Queen's University Belfast · GBTrinity College Dublin · IE

Funding

British Heart Foundation PG/14/9/30632
6 · The paper itself

Abstract

backgroundHistorically, high levels of morbidity and mortality have been associated with cardiovascular disease in the Northern Ireland population. Previously reported associations between single nucleotide polymorphisms (SNPs) and cardiovascular disease within other populations have not always been consistent.

objectiveTo investigate associations between 33 SNPs with fatal or non-fatal incident coronary heart disease (CHD) events and all-cause mortality in the Northern Irish participants of the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

methodPhase 2 of the PRIME study prospectively evaluated 2,010 men aged 58-74 years in Northern Ireland for more than 10 years for incident CHD events (myocardial infarction, percutaneous coronary intervention, coronary artery bypass, and cardiac death) and more than 15 years for all-cause mortality. SNPs previously reported in association with cardiovascular outcomes were evaluated against incident CHD events and all-cause mortality using Cox's proportional hazards models adjusted for established cardiovascular disease risk factors.

resultsDuring the follow-up period, 177 incident CHD events were recorded, and 821 men died. Both BCMO1 rs6564851 (Hazard ratio [HR] = 0.76; 95% confidence intervals [CI]: 0.60-0.96; P = 0.02) and TGFB1 rs1800469 (HR = 1.30; CI: 1.02-1.65; P = 0.04) were significantly associated with incident CHD events in adjusted models. Only IL1B rs16944 was significantly associated with all-cause mortality (HR = 1.18; CI: 1.05-1.33; P = 0.005). No associations remained significant following Bonferonni correction for multiple testing.

conclusionWe report a novel association between BCMO1 rs6564851 and risk of incident CHD events. In addition, TGFB1 rs1800469 and IL1B rs16944 were associated with the risk of incident CHD events and all-cause mortality outcomes respectively, supporting previously reported associations.

Indexed as

beta-Carotene 15,15'-MonooxygenaseCoronary DiseaseInterleukin-1betaMortalityMyocardial InfarctionTransforming Growth Factor beta1HumansIncidenceMaleNorthern IrelandProspective StudiesRisk FactorsBCO1 protein, humanbeta-Carotene 15,15'-MonooxygenaseIL1B protein, humanInterleukin-1betaTGFB1 protein, humanTransforming Growth Factor beta1

Identifiers

PMID35994463
PMCPMC9394803
OpenAlexW4292636240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.